LEONETTI, Francesco
LEONETTI, Francesco
DIPARTIMENTO DI FARMACIA-SCIENZE DEL FARMACO
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships
2008-01-01 Stefanachi, Angela; Nicolotti, Orazio; Leonetti, Francesco; Cellamare, Saverio; Campagna, Francesco; Loza, Mi; Brea, Jm; Mazza, F; Gavuzzo, E; Carotti, Angelo
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore
1997-01-01 Carrieri, Antonio; L., Brasili; Leonetti, Francesco; M., Pigini; M., Giannella; P., Bousquet; Carotti, Angelo
4-(Alkylamino)methyl-substituted coumarins as potent and selective AChE and MAO-B dual inhibitors with a therapeutic potential in neurodegenerative disorders
2013-01-01 Pisani, L.; Catto, M.; Stefanachi, A.; Leonetti, F.; Campagna, F.; Nicolotti, O.; Soto-Otero, R.; Carotti, A.
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor.
2010-01-01 Nicolotti, Orazio; Giangreco, I; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Cellamare, Saverio; Carotti, A.
A Multi-Objective Optimization Algorithm for Molecular Design
2009-01-01 Giangreco, I; Nicolotti, Orazio; Miscioscia T., F; Convertino, M; Mangiatordi G., F; Siragusa, L; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Carotti, A.
A multitarget approach in cancer research
2009-01-01 Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A.
A multitarget approach in cancer research. Joint Meeting on Medicinal Chemistry
2009-01-01 Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A.
A new approach to combine ligand- and structure-based drug design.
2008-01-01 Nicolotti, Orazio; Miscioscia, Tf; Carotti, A; Leonetti, Francesco; Giangreco, I; Carotti, A.
A novel function for non-deterministic scouting of optimal QSAR models out of a highly-structured physicochemical space.
2006-01-01 Nicolotti, Orazio; Miscioscia T., F; Leonetti, Francesco; Carotti, A.
An improved method for the biological evaluation of polyphenol derivatives as potential inhibitors of aβ(1–40) aggregation
2009-01-01 Stolfa, A; Cellamare, Saverio; Stefanachi, Angela; Catto, Marco; Leonetti, Francesco; Nicolotti, Orazio; Carotti, A.
An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors
2008-01-01 Nicolotti, Orazio; Miscioscia, Tf; Carotti, Angelo; Leonetti, Francesco; Carotti, A.
An integrated methodology to interface structure- and ligand-based drug design
2008-01-01 Giangreco, I; Nicolotti, Orazio; Miscioscia, Tf; Tedeschi, P; Carotti, A; Leonetti, Francesco; Carotti, A.
Attenuation of autoimmune disease in fas-deficient mice by treatment with a cytotoxic benzodiazepine
2003-01-01 Bednarski, J. J.; Warner, R. E.; Rao, T.; Leonetti, Francesco; Yung, R.; Richardson, B. C.; Johnson, K. J.; Ellman, J. A.; OPIPARI JR, A. W.; Glick, G. D.
Automated identification of structurally heterogeneous and patentable antiproliferative hits as potential tubulin inhibitors
2018-01-01 Mangiatordi, G. F.; Trisciuzzi, D.; Iacobazzi, R.; Denora, N.; Pisani, L.; Catto, M.; Leonetti, F.; Alberga, D.; Nicolotti, O.
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile
2011-01-01 Leonetti, Francesco; Stefanachi, Angela; Nicolotti, Orazio; Catto, Marco; Pisani, Leonardo; Cellamare, Saverio; Carotti, Angelo
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml
2020-01-01 Carofiglio, F.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Nicolotti, O.; Denora, N.; Stefanachi, A.; Leonetti, F.
Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility
2002-01-01 Blatt, N. B.; Bednarski, J. J.; Warner, R. E.; Leonetti, Francesco; Johnson, K. M.; Boitano, A.; Yung, R.; Richardson, B. C.; Johnson, K. J.; Ellman, J. A.; OPIPARI JR, A. W.; Glick, G. D.
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models
1999-01-01 Pigini, M; Bousquet, P; Brasili, L; Carrieri, Antonio; Dontewill, M; Gentili, F; Giannella, M; Leonetti, Francesco; Piergentili, A; Quaglia, W; Carotti, Angelo
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
2019-01-01 Porcelli, Letizia; Iacobazzi, Rosa Maria; Di Fonte, Roberta; Serrati', Simona; Intini, Angelica; Solimando, Antonio Giovanni; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola
Computational methods for the design of potent aromatase inhibitors
2013-01-01 Favia, Angelo Danilo; Nicolotti, Orazio; Stefanachi, Angela; Leonetti, Francesco; Carotti, Angelo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships | 1-gen-2008 | Stefanachi, Angela; Nicolotti, Orazio; Leonetti, Francesco; Cellamare, Saverio; Campagna, Francesco; Loza, Mi; Brea, Jm; Mazza, F; Gavuzzo, E; Carotti, Angelo | |
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore | 1-gen-1997 | Carrieri, Antonio; L., Brasili; Leonetti, Francesco; M., Pigini; M., Giannella; P., Bousquet; Carotti, Angelo | |
4-(Alkylamino)methyl-substituted coumarins as potent and selective AChE and MAO-B dual inhibitors with a therapeutic potential in neurodegenerative disorders | 1-gen-2013 | Pisani, L.; Catto, M.; Stefanachi, A.; Leonetti, F.; Campagna, F.; Nicolotti, O.; Soto-Otero, R.; Carotti, A. | |
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor. | 1-gen-2010 | Nicolotti, Orazio; Giangreco, I; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Cellamare, Saverio; Carotti, A. | |
A Multi-Objective Optimization Algorithm for Molecular Design | 1-gen-2009 | Giangreco, I; Nicolotti, Orazio; Miscioscia T., F; Convertino, M; Mangiatordi G., F; Siragusa, L; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Carotti, A. | |
A multitarget approach in cancer research | 1-gen-2009 | Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A. | |
A multitarget approach in cancer research. Joint Meeting on Medicinal Chemistry | 1-gen-2009 | Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A. | |
A new approach to combine ligand- and structure-based drug design. | 1-gen-2008 | Nicolotti, Orazio; Miscioscia, Tf; Carotti, A; Leonetti, Francesco; Giangreco, I; Carotti, A. | |
A novel function for non-deterministic scouting of optimal QSAR models out of a highly-structured physicochemical space. | 1-gen-2006 | Nicolotti, Orazio; Miscioscia T., F; Leonetti, Francesco; Carotti, A. | |
An improved method for the biological evaluation of polyphenol derivatives as potential inhibitors of aβ(1–40) aggregation | 1-gen-2009 | Stolfa, A; Cellamare, Saverio; Stefanachi, Angela; Catto, Marco; Leonetti, Francesco; Nicolotti, Orazio; Carotti, A. | |
An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors | 1-gen-2008 | Nicolotti, Orazio; Miscioscia, Tf; Carotti, Angelo; Leonetti, Francesco; Carotti, A. | |
An integrated methodology to interface structure- and ligand-based drug design | 1-gen-2008 | Giangreco, I; Nicolotti, Orazio; Miscioscia, Tf; Tedeschi, P; Carotti, A; Leonetti, Francesco; Carotti, A. | |
Attenuation of autoimmune disease in fas-deficient mice by treatment with a cytotoxic benzodiazepine | 1-gen-2003 | Bednarski, J. J.; Warner, R. E.; Rao, T.; Leonetti, Francesco; Yung, R.; Richardson, B. C.; Johnson, K. J.; Ellman, J. A.; OPIPARI JR, A. W.; Glick, G. D. | |
Automated identification of structurally heterogeneous and patentable antiproliferative hits as potential tubulin inhibitors | 1-gen-2018 | Mangiatordi, G. F.; Trisciuzzi, D.; Iacobazzi, R.; Denora, N.; Pisani, L.; Catto, M.; Leonetti, F.; Alberga, D.; Nicolotti, O. | |
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile | 1-gen-2011 | Leonetti, Francesco; Stefanachi, Angela; Nicolotti, Orazio; Catto, Marco; Pisani, Leonardo; Cellamare, Saverio; Carotti, Angelo | |
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml | 1-gen-2020 | Carofiglio, F.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Nicolotti, O.; Denora, N.; Stefanachi, A.; Leonetti, F. | |
Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility | 1-gen-2002 | Blatt, N. B.; Bednarski, J. J.; Warner, R. E.; Leonetti, Francesco; Johnson, K. M.; Boitano, A.; Yung, R.; Richardson, B. C.; Johnson, K. J.; Ellman, J. A.; OPIPARI JR, A. W.; Glick, G. D. | |
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models | 1-gen-1999 | Pigini, M; Bousquet, P; Brasili, L; Carrieri, Antonio; Dontewill, M; Gentili, F; Giannella, M; Leonetti, Francesco; Piergentili, A; Quaglia, W; Carotti, Angelo | |
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer | 1-gen-2019 | Porcelli, Letizia; Iacobazzi, Rosa Maria; Di Fonte, Roberta; Serrati', Simona; Intini, Angelica; Solimando, Antonio Giovanni; Brunetti, Oronzo; Calabrese, Angela; Leonetti, Francesco; Azzariti, Amalia; Silvestris, Nicola | |
Computational methods for the design of potent aromatase inhibitors | 1-gen-2013 | Favia, Angelo Danilo; Nicolotti, Orazio; Stefanachi, Angela; Leonetti, Francesco; Carotti, Angelo |